Prevention With the Health and Lifestyle Tool
Prevention and Development of Lifestyle Diseases With the Health and Lifestyle Tool
1 other identifier
interventional
77,000
1 country
1
Brief Summary
In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively via clinical registries follow the incidence and development of type 2 diabetes over three years in those using the tool regularly and those in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2021
CompletedFirst Posted
Study publicly available on registry
August 16, 2021
CompletedStudy Start
First participant enrolled
August 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 14, 2025
July 1, 2025
5 years
August 9, 2021
August 10, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Incidence of type 2 diabetes
Incidence of type 2 diabetes defined as random plasma glucose \>11.1 mmol/L or fasting glucose \>7.0 mmol/L or HbA1C ≥6.5% compared between participants regularly using the tool and on usual care.
3 years
Change of long-term blood glucose concentration measured as glycated hemoglobin at end of follow-up
Intraindividual change of long-term blood glucose concentration measured as glycated hemoglobin (HbA1c) at end of follow-up relative to baseline compared between participants regularly using the tool and on usual care.
3 years
Prescription of anxiolytic medication
Number of participants on prescription of anxiolytic medication between participants regularly using the tool and on usual care.
3 years
Prescription of antidepessive medication
Number of participants on prescription of antidepressive medication between participants regularly using the tool and on usual care.
3 years
Secondary Outcomes (2)
Change of Anxiety estimated by General Anxiety Disorder 7-item scale
1 year
Change of Patient Health Questionnaire 9-item scale
1 year
Study Arms (2)
Usage of tool
EXPERIMENTALParticipants get access to the tool and use it regularly
Controls on usual care
NO INTERVENTIONParticipants who get randomized to control cannot access the tool and get no further follow-up. Their development of type 2 diabetes or development of HbA1c is tracked via clinical registries.
Interventions
Eligibility Criteria
You may qualify if:
- informed consent
- Age above 35 years
You may not qualify if:
- type 1 diabetes, MODY or secondary diabetes
- conditions or treatments that in the judgement of the Investigator could affect the study evaluation
- connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Anders Rosengrentest
Malmo, Skåne County, 20502, Sweden
Related Publications (1)
Dwibedi C, Abrahamsson B, Rosengren AH. Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2 Diabetes. Diabetes Ther. 2022 Mar;13(3):423-439. doi: 10.1007/s13300-022-01214-2. Epub 2022 Feb 12.
PMID: 35150403DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Anders Rosengren, Prof
Göteborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2021
First Posted
August 16, 2021
Study Start
August 16, 2021
Primary Completion (Estimated)
August 15, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available after publication.
- Access Criteria
- To researchers who provide a methodologically sound proposal in order to achieve the aims of that proposal. Proposals should be directed by email to internetverktyg@gu.se
Individual participant data that underlie the results will be shared after deidentification.